People in the UK bereaved during the first nine months of the COVID-19 pandemic showed higher levels of grief and support needs if they were socially isolated or lonely.
Drugs that repair damage to a gel-like layer in the tiny blood vessels of the heart could present a much-needed treatment for heart failure in people with diabetes, according to University of Bristol-led research funded by the British Heart Foundation and published today in Diabetologia.
New research from the universities of Surrey and Bristol and ESPCI Paris has shown that FFP2 (filtering facepiece) respirator masks are five times more efficient at filtering particles which carry the Covid-19 virus than cloth masks.
Only one in three patients are diagnosed with broken bones in the back due to osteoporosis.
Researchers from the University of Bristol have found that there have been increases in incident prescribing of most anti-anxiety medications (called anxiolytics) in recent years, which have been substantial in young adults (aged under 25).
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months according to a new international study led in the UK by researchers at the University of Bristol and Imperial College London.
Identifying genetic risk factors for Alzheimer's disease is essential if we are to improve our understanding and treatment of it.
People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found.
A new systematic review and meta-analysis published in the scientific journal Addiction and led by University of Bristol researchers shows that maternal prenatal smoking is associated with offspring attention-deficit hyperactivity disorder (ADHD) but is unlikely to be the cause of it.
New research shows that lifelong excess weight almost doubles a woman’s risk of developing womb cancer*, according to a Cancer Research UK-funded study led by the University of Bristol and published today [19 April] in BMC Medicine**.
Being overweight in childhood increases the risk of developing type 1 diabetes in later life, according to the findings of a new study that analysed genetic data on over 400,000 individuals.
Cardiac surgery patients may experience different levels of disruption to their body producing life-saving hormones during their operations, a new study reveals.
A team of researchers, at the University of Bristol in the United Kingdom, has made a significant breakthrough in improving the precision of medical needle-use during surgical simulation.
The Liver4Life research team, is comprised of scientists from the University Hospital Zurich (USZ), ETH Zurich. The university has achieved an extraordinary breakthrough in the field of medicine.
COVID-19, in its multiple variants and its ability to thwart efforts to wipe it out, still has a lot of unknowns that make it impossible for scientists to declare victory over the disease, despite vaccines.
Researchers at the University of Zurich have found the Alongshan virus in Swiss ticks for the first time and now are developing a diagnostic test for their discovery, according to a UZH News article.
Researchers have discovered a protein that could help develop new home tests for a variety of diseases, according to a University of Texas at Austin news release.
An additional bivalent booster offers extra protection for those at high risk of COVID-19-related hospitalization and death.
A study conducted by UZH and the USZ has examined how blood stem cell transplantation treats MS and how the immune system heals afterward.
Texas A&M researchers have made a significant breakthrough in cancer treatment with the development of light-switchable CAR T-cell therapy (LiCAR-T).